The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: rituximab     Quarter: 2016Q3

Total Records: 1,104     Number of Pages: 56

DRUGNAME PT EventCount
Rituximab Influenza like illness 5
Rituximab JC virus infection 5
RITUXIMAB Joint arthroplasty 5
Rituximab Loss of consciousness 5
RITUXIMAB Mobility decreased 5
Rituximab Oesophageal carcinoma 5
Rituximab Onychomycosis 5
RITUXIMAB Pneumaturia 5
Rituximab Prostatitis 5
Rituximab Prostatitis Escherichia coli 5
RITUXIMAB Pulmonary oedema 5
RITUXIMAB Pyuria 5
RITUXIMAB Sinus node dysfunction 5
RITUXIMAB Sleep disorder 5
Rituximab Staphylococcal bacteraemia 5
Rituximab Urinary bladder abscess 5
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) Pyrexia 5
RITUXIMAB Abulia 4
RITUXIMAB Acute respiratory distress syndrome 4
Rituximab Alanine aminotransferase increased 4

Total Records: 1,104     Number of Pages: 56